Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.270 | 1.320 | 0.050 |
Stocks | 98.720 | 98.730 | 0.010 |
Other | 0.010 | 0.010 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.826 | 18.062 |
Price to Book | 3.084 | 3.048 |
Price to Sales | 2.332 | 2.223 |
Price to Cash Flow | 12.870 | 12.380 |
Dividend Yield | 2.097 | 2.030 |
5 Years Earnings Growth | 11.844 | 10.886 |
Name | Net % | Category Average |
---|---|---|
Technology | 32.390 | 23.910 |
Industrials | 19.880 | 11.496 |
Healthcare | 11.330 | 13.129 |
Financial Services | 9.960 | 16.340 |
Consumer Cyclical | 9.170 | 10.631 |
Basic Materials | 8.040 | 4.017 |
Communication Services | 5.520 | 7.802 |
Consumer Defensive | 1.650 | 7.678 |
Utilities | 1.370 | 2.633 |
Real Estate | 0.460 | 2.766 |
Energy | 0.210 | 3.559 |
Number of long holdings: 325
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 8.54 | 237.59 | -0.74% | |
Nordea Invest Emerging Markets | DK0010308170 | 7.61 | 143.510 | +0.20% | |
Microsoft | US5949181045 | 5.60 | 414.99 | -6.18% | |
Nordea 2 - EM Enhanced Equity Y DKK | LU0994674017 | 2.58 | - | - | |
Novo Nordisk B | DK0062498333 | 2.17 | 603.7 | -0.66% | |
NVIDIA | US67066G1040 | 2.02 | 124.65 | +0.77% | |
ABB | CH0012221716 | 1.64 | 50.14 | -1.84% | |
Rio Tinto PLC | GB0007188757 | 1.63 | 4,861.0 | +0.33% | |
Nordea 2 - Global Enhanced Sm Cap Y DKK | LU0994677622 | 1.38 | - | - | |
Eli Lilly | US5324571083 | 1.37 | 823.23 | +2.38% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nordea Invest Portefolje Aktier | 29.13B | 18.40 | 6.57 | 9.74 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review